Skip to content

The clinical study of pulsed radiofrequency combined with repetitive transcranial magnetic stimulation for the treatment of postherpetic neuralgia

The clinical study of pulsed radiofrequency combined with repetitive transcranial magnetic stimulation for the treatment of postherpetic neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094468
Enrollment
Unknown
Registered
2024-12-23
Start date
2024-12-25
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia

Interventions

Pulse radio frequency + false transcranial magnetic stimulation group:Pulse radio frequency
Pulse radio frequency + transcranial magnetic stimulation group:Pulse radio frequency + Repeat transcranial magnetic stimulation

Sponsors

Affiliated hangzhou first people's hospital, zhejiang university school of medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Pain that lasts for more than 3 months after the herpes zoster rash heals, and the pain site is unilateral thoracolumbar segment; 2. At least moderate pain intensity (visual analogue score (VAS)>=3); 3. 18-80 years old (including 18 and 80 years old); 4. Only those who have effective diagnostic nerve block can receive pulse therapy; 5. No history of other treatment plan adjustments within two weeks before and during the admission test; 6. Able to cooperate with the completion of assessment and treatment; 7. Understand and be willing to participate in this clinical trial and provide signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with severe mental illness, aphasia and cognitive impairment due to various reasons, who are unable to cooperate with assessment and treatment; 2.There are serious cardiopulmonary dysfunction, extreme weakness and other unstable conditions; 3.Pregnant or intending to become pregnant within six months; 4.Malignant tumor; 5.Coagulation dysfunction; 6.The presence of other causes of pain in the same area, such as lumbar fractures, myelopathy, multiple sclerosis, etc; 7.People with a history of epileptoid seizures/seizures/taking antiepileptic drugs; 8.People with a history of epileptoid seizures/seizures/taking antiepileptic drugs; 9.Metal implantation of the latter: pacemaker, spinal cord stimulator, vascular stent, fracture plate and so on.

Design outcomes

Primary

MeasureTime frame
Electroencephalography;Visual analog scale(VAS);

Secondary

MeasureTime frame
Health status questionnaire;Generalized anxiety Scale(GAD-7);Pittsburgh Sleep Quality Index Scale;Drug quantification scale;DN4 scale;Pain global Change self-rating Scale(PGIC);

Countries

China

Contacts

Public ContactYu Liang

Hangzhou First People's Hospital

yuliang0601@zju.edu.cn+86 13957162972

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026